Drug Approval Package

 Reyataz (atazanavir) Capsules
Company:  Bristol-Myers Squibb
Application No.:  021567
Approval Date: 6/20/2003

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)

• Medical Review(s) (PDF)  
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)

• Chemistry Review(s) (PDF)  

• Pharmacology Review(s) (PDF)

• Statistical Review(s) (PDF)

• Microbiology Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)  
  Part 4 (PDF)

• Administrative Document(s) (PDF)  
  Part 1 (PDF)  
  Part 2 (PDF)

• Correspondence (PDF)

Date created: September 9, 2003; Updated January 12, 2012

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.